- Home
- TRUE vs ENTX Comparison
TRUE vs ENTX Comparison
Compare TRUE & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUE
- ENTX
- Stock Information
- Founded
- TRUE 2005
- ENTX 2010
- Country
- TRUE United States
- ENTX Israel
- Employees
- TRUE N/A
- ENTX N/A
- Industry
- TRUE Computer Software: Programming Data Processing
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRUE Technology
- ENTX Health Care
- Exchange
- TRUE Nasdaq
- ENTX Nasdaq
- Market Cap
- TRUE 114.6M
- ENTX 104.0M
- IPO Year
- TRUE 2014
- ENTX 2018
- Fundamental
- Price
- TRUE $1.96
- ENTX $2.03
- Analyst Decision
- TRUE Buy
- ENTX Strong Buy
- Analyst Count
- TRUE 5
- ENTX 1
- Target Price
- TRUE $3.19
- ENTX $10.00
- AVG Volume (30 Days)
- TRUE 242.3K
- ENTX 35.0K
- Earning Date
- TRUE 08-04-2025
- ENTX 08-08-2025
- Dividend Yield
- TRUE N/A
- ENTX N/A
- EPS Growth
- TRUE N/A
- ENTX N/A
- EPS
- TRUE N/A
- ENTX N/A
- Revenue
- TRUE $179,356,000.00
- ENTX $223,000.00
- Revenue This Year
- TRUE $7.54
- ENTX N/A
- Revenue Next Year
- TRUE $11.02
- ENTX N/A
- P/E Ratio
- TRUE N/A
- ENTX N/A
- Revenue Growth
- TRUE 10.18
- ENTX N/A
- 52 Week Low
- TRUE $1.05
- ENTX $1.41
- 52 Week High
- TRUE $4.62
- ENTX $2.79
- Technical
- Relative Strength Index (RSI)
- TRUE 60.44
- ENTX 58.57
- Support Level
- TRUE $1.94
- ENTX $1.72
- Resistance Level
- TRUE $2.01
- ENTX $1.88
- Average True Range (ATR)
- TRUE 0.10
- ENTX 0.11
- MACD
- TRUE -0.00
- ENTX 0.03
- Stochastic Oscillator
- TRUE 73.77
- ENTX 91.89
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.